 Home > Medical News > Latest Medical News > Puri Pharmaceuticals Pantoprazole Sodium for Injection Receives Health Canada Approval

Puri Pharmaceuticals Pantoprazole Sodium for Injection Receives Health Canada Approval

 Last Update: 2021-06-22
 Source: Internet
 Author: User

Tags

proton pump inhibitor drugs

long acting injectables

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On June 3, Prism Pharmaceuticals issued an announcement stating that it had recently received a notice of approval of Pantoprazole Sodium for Injection issued by Health Canada
.

Pantoprazole Sodium for Injection is a selective long-acting proton pump inhibitor
.

The molecule is composed of benzimidazole connected to the pyridine ring through a sulfoxide group.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.